Modified fragment of human growth hormone (residues 176-191).
Stimulates lipolysis and inhibits lipogenesis without affecting blood glucose or IGF-1.
Use
Targeted fat loss, particularly stubborn adipose tissue.
Route
Subcutaneous injection, daily, typically morning fasted.
Pairs with
Ipamorelin or Sermorelin nightly. GLP-1 weekly. Resistance training.
Status
Investigational. Compounded.